Brian M. Stoltz is currently a professor of chemistry at the California Institute of Technology. The primary focus of his research is chemical synthesis with an emphasis on the development of new strategies for the preparation of complex molecules possessing unique structural, biological, and physical properties. His research involves the total synthesis of natural products such as dragmacidin F and (–)-cyanthiwigin F, and development of synthetic reactions to access quaternary stereocenters. Specifically, he has focused on the allylic alkylation of enolates, developing an enantioselective variant in 2004.Several former members of the Stoltz laboratory have gone on to start research groups of their own, such as Richmond Sarpong (UC-Berkeley), Uttam Tambar (UT-Southwestern Medical Center), Neil Garg (UCLA), Eric Ferreira (Georgia Tech) and Hosea Nelson (UCLA).